Israel Englander Merus N.V. Transaction History

Millennium Management LLC

$207 Billion
Q2 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Merus N.V. stock. As of the latest transaction made, Millennium Management LLC holds 243,257 shares of MRUS stock, worth $12.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

243,257

Previous 150,270 61.88%

Holding current value

$12.9 Million

Previous $6.77 Million 112.73%

% of portfolio

0.01%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$39.81 - $60.2 $3.7 Million - $5.6 Million	92,987 Added 61.88%	243,257 $14.4 Million
Q1 2024 May 15, 2024	SELL	$28.03 - $51.82 $15.2 Million - $28.1 Million	-543,057 Reduced 78.33%	150,270 $6.77 Million
Q4 2023 Feb 14, 2024	BUY	$20.06 - $28.66 $13.4 Million - $19.2 Million	669,015 Added 2751.79%	693,327 $19.1 Million
Q2 2023 Aug 14, 2023	BUY	$18.33 - $27.18 $139,509 - $206,866	7,611 Added 45.57%	24,312 $640,000
Q1 2023 May 15, 2023	SELL	$14.25 - $20.5 $4.62 Million - $6.64 Million	-324,004 Reduced 95.1%	16,701 $307,000
Q4 2022 Feb 14, 2023	SELL	$12.8 - $23.66 $2.41 Million - $4.46 Million	-188,598 Reduced 35.63%	340,705 $5.27 Million
Q3 2022 Nov 14, 2022	SELL	$18.64 - $28.93 $5.92 Million - $9.19 Million	-317,754 Reduced 37.51%	529,303 $10.6 Million
Q2 2022 Aug 15, 2022	BUY	$13.98 - $29.25 $5.5 Million - $11.5 Million	393,771 Added 86.87%	847,057 $19.2 Million
Q1 2022 May 16, 2022	SELL	$23.58 - $30.91 $7.58 Million - $9.94 Million	-321,481 Reduced 41.49%	453,286 $12 Million
Q4 2021 Feb 14, 2022	BUY	$20.0 - $32.29 $4.36 Million - $7.05 Million	218,244 Added 39.22%	774,767 $24.6 Million
Q3 2021 Nov 15, 2021	BUY	$16.48 - $27.23 $3.9 Million - $6.44 Million	236,364 Added 73.83%	556,523 $12.2 Million
Q2 2021 Aug 16, 2021	BUY	$20.0 - $25.48 $3.63 Million - $4.63 Million	181,564 Added 131.0%	320,159 $6.75 Million
Q1 2021 May 17, 2021	BUY	$16.14 - $29.11 $1.84 Million - $3.32 Million	114,217 Added 468.52%	138,595 $2.9 Million
Q4 2020 Feb 16, 2021	SELL	$11.4 - $18.36 $287,838 - $463,571	-25,249 Reduced 50.88%	24,378 $427,000
Q3 2020 Nov 16, 2020	SELL	$10.57 - $16.0 $778,755 - $1.18 Million	-73,676 Reduced 59.75%	49,627 $596,000
Q2 2020 Aug 14, 2020	BUY	$10.5 - $17.36 $1.29 Million - $2.14 Million	123,303 New	123,303 $1.98 Million
Q3 2018 Nov 14, 2018	SELL	$18.47 - $26.39 $260,371 - $372,019	-14,097 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$16.77 - $22.76 $5,601 - $7,601	-334 Reduced 2.31%	14,097 $321,000
Q1 2018 May 15, 2018	BUY	$16.07 - $19.87 $231,906 - $286,743	14,431 New	14,431 $267,000

Others Institutions Holding MRUS

# of Institutions

195

Shares Held

59.2M

Call Options Held

345K

Put Options Held

222K

View Full List

About Merus N.V.

Ticker MRUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,878,200
Market Cap $2.44B
Description
Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...

More about MRUS

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account